Business Context and Reporting Period
This Form 8-K Current Report from Clarivate Plc covers the 2024 Annual General Meeting of Shareholders held on May 7, 2024. The report details the voting outcomes for three shareholder proposals and announces the date for the 2025 Annual General Meeting.
Key Financial Metrics
This filing is a corporate governance report and does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The filing text does not provide a clear value for any financial indicators.
Material Changes and Voting Results
Shareholders approved all three proposals presented at the meeting. Of 668,143,386 ordinary shares outstanding, 605,939,435 were present, constituting a quorum.
- Proposal 1: Election of Directors - All 12 nominees were elected. While all received majority support, some directors faced notable opposition:
- Wendell Pritchett received 45,069,213 votes against (approx. 7.5% of votes cast).
- Richard W. Roedel received 41,407,129 votes against (approx. 7.0% of votes cast).
- Valeria Alberola and Anthony Munk each received over 34 million votes against.
- Proposal 2: Advisory Approval of Executive Compensation - Approved with 582,480,148 votes for and 4,825,077 votes against.
- Proposal 3: Ratification of Independent Registered Public Accountants - PricewaterhouseCoopers LLP was ratified with 603,750,294 votes for and 2,138,490 votes against.
Guidance, Outlook, and Other Events
Future Events: The Company announced that the 2025 Annual General Meeting of Shareholders will be held on May 7, 2025. Further details will be provided in the future proxy statement.
Management Commentary: The filing contains no management commentary regarding business strategy, risks, or contingencies beyond the procedural details of the shareholder meeting.
Investor Verification Checklist
- Verify the specific reasons for the higher-than-average "Against" votes for directors Wendell Pritchett, Richard W. Roedel, Valeria Alberola, and Anthony Munk by reviewing the definitive proxy statement dated March 25, 2024.
- Confirm the terms of office for the newly elected directors, which expire at the 2025 Annual General Meeting.
- Note that this filing does not update financial guidance; investors should refer to the most recent 10-K or 10-Q for financial performance.